Pharmaceuticals

Pharmaceuticals Stock Market Investments Corporate Finance Investment Market Trends Earnings Reports Pharmaceuticals Market Analysis Mergers and Acquisitions

8 ARTICLES

3d ago

Hims & Hers Shares Drop on Weak Q2 Guidance Despite Strong Q1 Results

The telehealth company posted a robust Q1 earnings beat but faces investor concerns over softer Q2 forecasts and the transition from compounded to branded semaglutide offerings.

3 ARTICLES

last wk.

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

8 ARTICLES

last wk.

CVS Health Beats Q1 Expectations and Raises 2025 Earnings Guidance

8 ARTICLES

last wk.

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

6 ARTICLES

last wk.

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

10 ARTICLES

last wk.

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

6 ARTICLES

last wk.

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

3 ARTICLES

2w ago

AbbVie Raises 2025 Profit Forecast Following Strong Q1 Growth in Immunology Drugs

9 ARTICLES

2w ago

Indian Pharmaceuticals Exempt from Trump's Tariffs, Boosting Stock Market Confidence

8 ARTICLES

last mo.

Hims & Hers Expands Weight-Loss Offerings with New Medications

4 ARTICLES

last mo.

Novo Holdings Reports Record Income Despite Novo Nordisk's Market Decline

5 ARTICLES

last mo.

Isomorphic Labs Secures $600M to Advance AI-Driven Drug Discovery

3 ARTICLES

last mo.

Sanofi Secures $1.9 Billion Deal for Dren Bio’s Innovative Autoimmune Therapy

3 ARTICLES

last mo.

Pfizer Completes £2.5 Billion Sale of Remaining Stake in Haleon

4 ARTICLES

last mo.

Mallinckrodt and Endo to Merge in $6.7 Billion Deal

3 ARTICLES

last mo.

Bristol Myers Squibb to Acquire 2seventy Bio in $286 Million Deal

Particle.news

Pharmaceuticals

Hims & Hers Shares Drop on Weak Q2 Guidance Despite Strong Q1 Results

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

CVS Health Beats Q1 Expectations and Raises 2025 Earnings Guidance

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

AbbVie Raises 2025 Profit Forecast Following Strong Q1 Growth in Immunology Drugs

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Never miss stories about

Pharmaceuticals

Walgreens Reaches $300 Million Settlement Over Invalid Opioid Prescriptions

Johnson & Johnson Exceeds Q1 Estimates, Boosts Revenue Forecast

Indian Pharmaceuticals Exempt from Trump's Tariffs, Boosting Stock Market Confidence

Hims & Hers Expands Weight-Loss Offerings with New Medications

Novo Holdings Reports Record Income Despite Novo Nordisk's Market Decline

Isomorphic Labs Secures $600M to Advance AI-Driven Drug Discovery

Sanofi Secures $1.9 Billion Deal for Dren Bio’s Innovative Autoimmune Therapy

Pfizer Completes £2.5 Billion Sale of Remaining Stake in Haleon

Mallinckrodt and Endo to Merge in $6.7 Billion Deal

Bristol Myers Squibb to Acquire 2seventy Bio in $286 Million Deal

Never miss stories about

Pharmaceuticals